{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:40:55Z","timestamp":1778794855531,"version":"3.51.4"},"reference-count":73,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hematopoietic stem cell transplantation (HSCT) is widely used in benign and malignant hematological diseases. During the last decade, HSCT, mainly autologous, also gained increasing attention in the treatment of refractory autoimmune diseases. Crohn\u2019s disease (CD) is an inflammatory bowel disease leading to transmural inflammation potentially affecting all parts of the luminal gastrointestinal tract. Despite improving therapeutic options, including various biologics, some patients are refractory to all lines of available conservative therapy, leading to increased morbidity and reduced quality of life. Apart from surgery, HSCT might be a reasonable treatment alternative for refractory CD patients. This review aims to describe the current role of HSCT in CD and discusses the procedure, the correct patient selection, the clinical efficacy from initial remission to following relapse rates, and complications of this treatment.<\/jats:p>","DOI":"10.3390\/cells11213463","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T03:36:44Z","timestamp":1667360204000},"page":"3463","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hematopoietic Stem Cell Transplantation in Refractory Crohn\u2019s Disease: Should It Be Considered?"],"prefix":"10.3390","volume":"11","author":[{"given":"Simon","family":"Reider","sequence":"first","affiliation":[{"name":"Christian Doppler Laboratory for Mucosal Immunology, Johannes Kepler University Linz, 4020 Linz, Austria"},{"name":"Department of Internal Medicine 2 (Gastroenterology and Hepatology), Faculty of Medicine, Kepler University Hospital, Johannes Kepler University, 4020 Linz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Binder","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-7546","authenticated-orcid":false,"given":"Stefan","family":"F\u00fcrst","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6266-0512","authenticated-orcid":false,"given":"Stefan","family":"Hatzl","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"},{"name":"Division of Hematology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-4140","authenticated-orcid":false,"given":"Andreas","family":"Blesl","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mayocp.2017.04.010","article-title":"Crohn Disease: Epidemiology, Diagnosis, and Management","volume":"92","author":"Feuerstein","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1016\/j.cgh.2021.03.021","article-title":"A Systematic Review of Monogenic Inflammatory Bowel Disease","volume":"20","author":"Nambu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2014.07.023","article-title":"The diagnostic approach to monogenic very early onset inflammatory bowel disease","volume":"147","author":"Uhlig","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MOG.0000000000000740","article-title":"New targets in inflammatory bowel disease therapy: 2021","volume":"37","author":"Cohen","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_7","first-page":"e8351","article-title":"Medical Management of Crohn\u2019s Disease","volume":"12","author":"Gade","year":"2020","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ecco-jcc\/jjab133","article-title":"Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn\u2019s Disease: Results From the VISIBLE 2 Randomised Trial","volume":"16","author":"Vermeire","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as Induction and Maintenance Therapy for Crohn\u2019s Disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn\u2019s disease: Results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1053\/j.gastro.2020.01.047","article-title":"Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients with Crohn\u2019s Disease","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(22)00467-6","article-title":"Risankizumab as induction therapy for Crohn\u2019s disease: Results from the phase 3 ADVANCE and MOTIVATE induction trials","volume":"399","author":"Panaccione","year":"2022","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-13-2-357","article-title":"Aplastic anemia treated with daily transfusions and intravenous marrow; case report","volume":"13","author":"Osgood","year":"1939","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e0028","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation-50 years of evolution and future perspectives","volume":"5","author":"Henig","year":"2014","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","article-title":"Haematopoietic stem cell transplantation for autoimmune diseases","volume":"13","author":"Swart","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3324\/haematol.2009.017038","article-title":"Stem cell transplantation for autoimmune diseases","volume":"95","author":"Daikeler","year":"2010","journal-title":"Haematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.htct.2020.03.002","article-title":"A review of hematopoietic stem cell transplantation for autoimmune diseases: Multiple sclerosis, systemic sclerosis and Crohn\u2019s disease. Position paper of the Brazilian Society of Bone Marrow Transplantation","volume":"43","author":"Oliveira","year":"2021","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2018.00646","article-title":"Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn\u2019s Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators","volume":"9","author":"Pockley","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.bmt.1702621","article-title":"Crohn\u2019s disease complicated by relapsed extranodal Hodgkin\u2019s lymphoma: Prolonged complete remission after unmanipulated PBPC autotransplant","volume":"26","author":"Musso","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/01.TP.0000062540.29757.E9","article-title":"Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation","volume":"75","author":"Ditschkowski","year":"2003","journal-title":"Transplantation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ajh.2830430223","article-title":"Case of Crohn\u2019s disease in bone marrow transplantation","volume":"43","author":"Drakos","year":"1993","journal-title":"Am. J. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2141.1998.01059.x","article-title":"Autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma resulting in long-term remission of coincidental Crohn\u2019s disease","volume":"103","author":"Kashyap","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0016-5085(98)70525-6","article-title":"Course of Crohn\u2019s disease after allogeneic marrow transplantation","volume":"114","author":"Sullivan","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4252\/wjsc.v10.i10.134","article-title":"Hematopoietic stem cell transplantation for Crohn\u2019s disease: Gaps, doubts and perspectives","volume":"10","author":"Ruiz","year":"2018","journal-title":"World J. Stem Cells"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ecco-jcc\/jjx184","article-title":"Autologous Haematopoietic Stem Cell Transplantation (AHSCT) in Severe Crohn\u2019s Disease: A Review on Behalf of ECCO and EBMT","volume":"12","author":"Snowden","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s00520-017-3716-6","article-title":"Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: Influencing risk factors and impact on survival","volume":"25","author":"Elzimaity","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5217\/ir.2019.00107","article-title":"The prevalence of sarcopenia and its effect on prognosis in patients with Crohn\u2019s disease","volume":"18","author":"Lee","year":"2020","journal-title":"Intest. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.10-2889","article-title":"Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant","volume":"141","author":"Afessa","year":"2012","journal-title":"Chest"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11936-016-0447-9","article-title":"Cardiovascular Complications of Hematopoietic Stem Cell Transplantation","volume":"18","author":"Blaes","year":"2016","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41409-019-0430-7","article-title":"General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)","volume":"54","author":"Jessop","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/07357907.2014.919301","article-title":"Complications of allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Arnaout","year":"2014","journal-title":"Cancer Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1703081","article-title":"Collection of hematopoietic stem cells from patients with autoimmune diseases","volume":"28","author":"Burt","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bmt.1705579","article-title":"Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation","volume":"39","author":"Statkute","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_36","first-page":"1878","article-title":"Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares","volume":"33","author":"Vasiliu","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00054725-200411000-00027","article-title":"Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn\u2019s disease refractory to immunosuppressive and immunomodulator therapy","volume":"10","author":"Cavallaro","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1182\/blood-2010-06-292391","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: Long-term follow-up","volume":"116","author":"Burt","year":"2010","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/gut.2007.128694","article-title":"Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn\u2019s disease","volume":"57","author":"Cassinotti","year":"2008","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.crohns.2011.05.004","article-title":"Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn\u2019s disease","volume":"5","author":"Hommes","year":"2011","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/apt.12032","article-title":"Remission of refractory Crohn\u2019s disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation","volume":"36","author":"Hasselblatt","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/qjmed\/hcu095","article-title":"Autologous stem cell transplantation in severe treatment-resistant Crohn\u2019s disease: Long-term follow-up of UK patients treated on compassionate basis","volume":"107","author":"Snowden","year":"2014","journal-title":"QJM"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gutjnl-2015-309836","article-title":"Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn\u2019s disease","volume":"65","author":"Rovira","year":"2016","journal-title":"Gut"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ecco-jcc\/jjx054","article-title":"Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn\u2019s Disease: Efficacy in a Single-Centre Cohort","volume":"11","author":"Rovira","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2015.16700","article-title":"Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial","volume":"314","author":"Hawkey","year":"2015","journal-title":"JAMA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(17)30056-0","article-title":"Autologous stem-cell transplantation in treatment-refractory Crohn\u2019s disease: An analysis of pooled data from the ASTIC trial","volume":"2","author":"Lindsay","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ecco-jcc\/jjx180.020","article-title":"Autologous Haematopoietic Stem Cell Transplantation for Crohn\u2019s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation","volume":"12","author":"Brierley","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gastrohep.2018.08.004","article-title":"Autologous haematopoietic stem cell transplantation in refractory Crohn\u2019s disease: Experience in our centre","volume":"42","author":"Hernanz","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41409-020-0953-y","article-title":"A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease","volume":"55","author":"Burt","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.retram.2016.03.003","article-title":"Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice","volume":"64","author":"Kelsey","year":"2016","journal-title":"Curr. Res. Transl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2002-07-2122","article-title":"High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease","volume":"101","author":"Burt","year":"2003","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/sj.bmt.1703945","article-title":"Hematopoietic stem cell transplantation for severe Crohn\u2019s disease","volume":"32","author":"Craig","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"ref_54","first-page":"Cd013070","article-title":"Stem cell transplantation for induction of remission in medically refractory Crohn\u2019s disease","volume":"5","author":"Shawky","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s15010-011-0229-y","article-title":"Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients","volume":"40","author":"Mikulska","year":"2012","journal-title":"Infection"},{"key":"ref_56","first-page":"e24807","article-title":"A Systematic Review on Pulmonary Complications Secondary to Hematopoietic Stem Cell Transplantation","volume":"14","author":"Busmail","year":"2022","journal-title":"Cureus"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis","volume":"19","author":"Torres","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2015.330","article-title":"Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Tanaka","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"ref_60","first-page":"362","article-title":"HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation","volume":"136","author":"Petersdorf","year":"2020","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2017-315568","article-title":"Natural disease course of Crohn\u2019s disease during the first 5 years after diagnosis in a European population-based inception cohort: An Epi-IBD study","volume":"68","author":"Burisch","year":"2019","journal-title":"Gut"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1053\/j.gastro.2022.01.047","article-title":"Guselkumab for the Treatment of Crohn\u2019s Disease: Induction Results From the Phase 2 GALAXI-1 Study","volume":"162","author":"Sandborn","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: Role of conditioning regimen used","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/apt.16785","article-title":"Review article: Emerging drug therapies in inflammatory bowel disease","volume":"55","author":"Grossberg","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S2468-1253(21)00141-2","article-title":"Defining difficult-to-treat inflammatory bowel disease: Why and how","volume":"6","author":"Danese","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Surgical Treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/stem.1357","article-title":"Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn\u2019s fistula","volume":"31","author":"Lee","year":"2013","journal-title":"Stem Cells"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MIB.0000000000000988","article-title":"A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn\u2019s Disease","volume":"23","author":"Bettenworth","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/BF02055108","article-title":"Reoperative rates for Crohn\u2019s disease following strictureplasty. Long-term analysis","volume":"39","author":"Ozuner","year":"1996","journal-title":"Dis. Colon Rectum"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/DCR.0b013e318258f5cb","article-title":"Strictureplasty in selected Crohn\u2019s disease patients results in acceptable long-term outcome","volume":"55","author":"Bellolio","year":"2012","journal-title":"Dis. Colon Rectum"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/ibd.22940","article-title":"Exclusive antagonism of the \u03b14 \u03b27 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates","volume":"18","author":"Fedyk","year":"2012","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3463\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:03Z","timestamp":1760144943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":73,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["cells11213463"],"URL":"https:\/\/doi.org\/10.3390\/cells11213463","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}